Cipla to launch cinacalcet hydrochloride tablets in USA
NEW DELHI: Drug major Cipla and its subsidiary Cipla USA on Wednesday announced a phased launch of generic cinacalcet hydrochloride tablets, used in the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis, in the US market. The launch, however, is a subject of ongoing litigation, Cipla said in a […]